I think that is really worth mentioning I agree JellyRoll - both the Neurology category breakdown to find a more specific peer comparable Phase III success figure as you have noted, but also the repurposed drug element remove some tail risks associated with side effects etc prevalent in other Phase III trials and absent from ours.
Thanks mate!
- Forums
- ASX - By Stock
- IXC
- Twiggy's Invex Therapeutics | The Imminent Coin Flip
Twiggy's Invex Therapeutics | The Imminent Coin Flip, page-18
-
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.006(9.09%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
6.7¢ | 7.2¢ | 6.7¢ | $4.668K | 66.50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 888 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 0.074 |
1 | 17361 | 0.067 |
1 | 100000 | 0.062 |
1 | 150000 | 0.060 |
1 | 100000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 888 | 1 |
0.083 | 4000 | 1 |
0.085 | 1000 | 1 |
0.090 | 131356 | 2 |
0.095 | 100000 | 1 |
Last trade - 11.00am 15/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online